Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.

Source:http://linkedlifedata.com/resource/pubmed/id/18308163

J. Am. Coll. Cardiol. 2008 Mar 4 51 9 933-43

Download in:

View as

General Info

PMID
18308163